By Professor Ruth Peters

Preprints

Keay L; Ren K; Nguyen H; Vajdic C; Odutola M; Gyawali R; Toomey M; Peters R; Ee N; Dillon L; Hackett M; Ah Tong B; D'Esposito F; Faulmann D; Burton M; Ramke J; Jalbert I, 2022, Risk factors common to leading eye health conditions and major non-communicable diseases: a rapid review and commentary, http://dx.doi.org/10.12688/f1000research.123815.1

Huque H; Eramudugolla R; Chidiac B; Ee N; Ehrenfeld L; Matthews FE; Peters R; Anstey KJ, 2021, Global Distribution of Sex Differences in the Incidence and Prevalence of Any Dementia, Alzheimer's Disease, and Vascular Dementia: A Systematic Review and Meta-Analysis, http://dx.doi.org/10.2139/ssrn.3965370

Ee N; Brady B; Sinclair C; Anstey KJ; Peters R, Ageing and Decision-making: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2024.10.09.24315136

Zheng L; Godbee K; Steiner GZ; Daylight G; Ee C; Hill TY; Hohenberg M; Lautenschlager NT; McDonald K; Pond D; Radford K; Anstey KJ; Peters R, Dementia Risk Reduction in Practice: The Knowledge, Opinions and Perspectives of Australian Healthcare Providers, http://dx.doi.org/10.1101/2020.07.01.20144550

Lin X; Delfino C; Carcel C; Venturelli PM; Naismith S; Woodward M; Peters R; Wijesuriya N; Law M; Harding IH; Wang X; Leder K; Hutchings O; Skiba M; Stecher X; Zomer E; Zoungas S; Anderson CS, Statistical analysis plan for the STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER) study: a randomised, open label, controlled trial in subjects with persistent neurological symptoms after COVID-19 infection, http://dx.doi.org/10.1101/2025.07.03.25330859

Back to profile page